Brief: Anterogen receives patent
June 14 (Reuters) - Anterogen Co Ltd 065660.KQ :
* Says it receives patent, named autologous and allogenic
adipose-derived stromal stem cell composition for treating
fistulas
* Says patent number is 12104964
Source text in Korean: https://goo.gl/rTaJIm
Further company coverage: 065660.KQ
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; Reuters Messaging:
Yinglan.Ma@thomsonreuters.com@reuters.net))
Recent news on Anterogen
See all newsBrief: S.Korea's Anterogen Says To Invest 3.8 Billion Won To Build New GMP Facility
Brief: Anterogen issues 3rd tranche convertible bonds worth 16 bln won
Brief: Anterogen to invest 7.1 bln won to set up central research institute and plant
Brief: Anterogen issues convertible bonds worth 18 bln won
Brief: Anterogen to issue 2nd series convertible bonds worth 18 bln won